We next looked for CSCs with CD44v6+/CD133+ phenotype among cells in these lines, as a CD44v6+/CD133+ phenotype has been associated with CSCs in tumors and in cells of colon cancers [35]. This evidence concerns the gene PROM1 and malignant colon neoplasm.